The epidemiology and disease outcomes of human T-lymphotropic virus type II.

DF Roucoux, EL Murphy - AIDS reviews, 2004 - europepmc.org
Human T-lymphotropic virus type II (HTLV-II) is a human retrovirus which is endemic in
Amerindian and pygmy tribes. Molecular subtypes show geographic segregation consistent …

Human T lymphotropic virus type II (HTLV-II): epidemiology, molecular properties, and clinical features of infection

WW Hall, R Ishak, SW Zhu, P Novoa… - JAIDS Journal of …, 1996 - journals.lww.com
Human T lymphotropic virus, type II (HTLV-II), infection has been shown to be endemic in a
number of American Indian populations, and high rates of infection have also been …

[PDF][PDF] HIV/human T-cell lymphotropic virus coinfection revisited: impact on AIDS progression

C Brites, J Sampalo, A Oliveira - AIDS Rev, 2009 - researchgate.net
Human T-cell lymphotropic viruses type 1 and 2 are retroviruses that share the same routes
of transmission as HIV-1. Since these agents are prevalent simultaneously in different parts …

Clinical and laboratory outcomes in HIV-1 and HTLV-1/2 coinfection: a systematic review

I Montano-Castellon, CSC Marconi, C Saffe… - Frontiers in Public …, 2022 - frontiersin.org
Aim To perform a systematic review to describe the available findings on clinical outcomes
in HIV-1 and HTLV-1/HTLV-2 co-infected individuals since 1995. Design This Systematic …

[PDF][PDF] Molecular and cellular interactions of HIV-1/HTLV coinfection and impact on AIDS progression

C Casoli, E Pilotti, U Bertazzoni - Aids Rev, 2007 - academia.edu
In the last 10 years HIV-1/human T-cell leukemia virus (HIV-1/HTLV) coinfection has
emerged as a worldwide health problem. The numbers of HIV-1/HTLV-1 coinfections in …

Current management of infectious complications in the injecting drug user

C Contoreggi, VE Rexroad, WR Lange - Journal of substance abuse …, 1998 - Elsevier
The diagnosis and management of infectious complications associated with injection drug
use (IDU) are among some of the more challenging aspects of working with substance …

HTLV-1/-2 and HIV-1 co-infections: retroviral interference on host immune status

E Pilotti, MV Bianchi, A De Maria, F Bozzano… - Frontiers in …, 2013 - frontiersin.org
The human retroviruses HIV-1 and HTLV-1/HTLV-2 share similar routes of transmission but
cause significantly different diseases. In this review we have outlined the immune mediated …

Increased all-cause and cancer mortality in HTLV-II infection

HH Biswas, Z Kaidarova, G Garratty… - JAIDS Journal of …, 2010 - journals.lww.com
Background: Human T-lymphotropic virus (HTLV)-I and HTLV-II cause chronic human
retroviral infections, but few studies have examined the impact of either virus on survival …

Neurological aspects of HIV-1/HTLV-1 and HIV-1/HTLV-2 coinfection

AQC Araujo - Pathogens, 2020 - mdpi.com
Simultaneous infection by human immunodeficiency viruses (HIV) and human T-
lymphotropic viruses (HTLV) are not uncommon since they have similar means of …

HTLV-II–associated cutaneous T-cell lymphoma in a patient with HIV-1 infection

B Poiesz, D Dube, S Dube, J Love… - … England Journal of …, 2000 - Mass Medical Soc
Patients infected with human immunodeficiency virus type 1 (HIV-1) are susceptible to
neoplasms, including Kaposi's sarcoma, non-Hodgkin's lymphoma, and anal and cervical …